Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Stalevo
Stalevo is a combination medication used to treat Parkinson's disease. It contains three active ingredients: levodopa, carbidopa, and entacapone. Levodopa is a precursor to dopamine, a neurotransmitter that is deficient in Parkinson's disease. Carbidopa helps prevent levodopa from being broken down before it reaches the brain, while entacapone prolongs the effects of levodopa by blocking an enzyme that breaks it down. This combination helps to improve motor control and reduce symptoms such as tremors, rigidity, and slow movement.
For the treatment of Parkinson's disease.
Outcome:
Hypertensive crisis
Mechanism:
Increased dopamine levels
Outcome:
Increased blood pressure
Mechanism:
Increased norepinephrine levels
Outcome:
Slightly reduced levodopa absorption
Mechanism:
Altered gastric pH
Most likely new formulation: Extended-release or sustained-release formulations to further improve symptom control and reduce fluctuations (Year: 2025, 60% confidence).
Based on current usage trends and ongoing research, there is a 70% likelihood of generic versions continuing to dominate the market share within the next 5 years.
Antiparkinson Agent
Hydrazine/Catechol/Nitrocatechol